Lv1
50 积分 2025-01-08 加入
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
16天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2个月前
已完结
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
2个月前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
2个月前
已完结
Pathophysiology and clinical manifestations of immune complex vasculitides
3个月前
已关闭
Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
3个月前
已完结
Effects of Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease: A Systemic Review and Meta-Analysis
4个月前
已完结
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
4个月前
已完结
皖公网安备34019202002308
